Accession Number: | 0000921895-22-001987 |
Date: | 2022-06-11 |
Issuer: | HARVARD BIOSCIENCE INC (HBIO) |
Original Submission Date: |
ROSSI MICHAEL A.
C/O HARVARD BIOSCIENCE, INC.
84 OCTOBER HILL ROAD
HOLLISTON, MA 01746
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2022-06-11 | F | 6,325 | d | $3.95 | 277,508 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the shares were disposed of to satisfy the reporting person's tax withholding obligation in connection with a performance restricted stock unit award previously granted to the reporting person that vested in part on june 11, 2022. |
f2 | include (a) 31,021 restricted stock units that will vest in three equal installments on december 29, 2022, 2023 and 2024, (b) 21,545 remaining restricted stock units that will vest on june 11, 2023, (c) 25,641 restricted stock units that will vest in two equal installments on december 29, 2022 and 2023, (d) 65,592 restricted stock units with performance based vesting conditions, (e) 23,878 remaining restricted stock units that will vest on july 18, 2022, (f) 21,545 remaining restricted stock units that will vest on december 29, 2022 and 2023, and (g) 88,286 shares of common stock beneficially owned by the reporting person. |